4//SEC Filing
MusclePharm Corp 4
Accession 0001144204-16-134486
CIK 0001415684operating
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 7:07 PM ET
Size
5.8 KB
Accession
0001144204-16-134486
Insider Transaction Report
Form 4
MusclePharm CorpMSLP
Drexler Ryan Charles
Director10% Owner
Transactions
- Other
Convertible Promissory Note
2016-11-10$1.83/sh+6,010,929$11,000,000→ 8,619,624 totalExercise: $1.83Exp: 2017-11-08→ Common Stock (6,010,929 underlying)
Footnotes (1)
- [F1]On November 8, 2016, Mr. Drexler entered into a convertible secured promissory note agreement (the "2016 Convertible Note") with the Company, pursuant to which, on November 10, 2016, Mr. Drexler loaned the Company $11.0 million. Mr. Drexler may elect to convert all or any portion of the convertible amount into shares of the Company's common stock at any time for $1.83 per share at any time (estimated to be approximately 6,010,929 shares as of the date of this Form 4). Both the principal and the interest under the 2016 Convertible Note are due in November 2017, unless converted earlier.
Documents
Issuer
MusclePharm Corp
CIK 0001415684
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001415684
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 7:07 PM ET
- Size
- 5.8 KB